These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

751 related items for PubMed ID: 8579895

  • 1. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone.
    Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, Whitfield GK.
    Bone; 1995 Aug; 17(2 Suppl):33S-38S. PubMed ID: 8579895
    [Abstract] [Full Text] [Related]

  • 2. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [Abstract] [Full Text] [Related]

  • 3. Salt concentration determines 1,25-dihydroxyvitamin D3 dependency of vitamin D receptor-retinoid X receptor--vitamin D-responsive element complex formation.
    Kimmel-Jehan C, Jehan F, DeLuca HF.
    Arch Biochem Biophys; 1997 May 01; 341(1):75-80. PubMed ID: 9143355
    [Abstract] [Full Text] [Related]

  • 4. Receptor mediated genomic action of the 1,25(OH)2D3 hormone: expression of the human vitamin D receptor in E. coli.
    Hsieh JC, Nakajima S, Galligan MA, Jurutka PW, Haussler CA, Whitfield GK, Haussler MR.
    J Steroid Biochem Mol Biol; 1995 Jun 01; 53(1-6):583-94. PubMed ID: 7626514
    [Abstract] [Full Text] [Related]

  • 5. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
    Staal A, van Wijnen AJ, Birkenhäger JC, Pols HA, Prahl J, DeLuca H, Gaub MP, Lian JB, Stein GS, van Leeuwen JP, Stein JL.
    Mol Endocrinol; 1996 Nov 01; 10(11):1444-56. PubMed ID: 8923469
    [Abstract] [Full Text] [Related]

  • 6. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
    Kephart DD, Walfish PG, DeLuca H, Butt TR.
    Mol Endocrinol; 1996 Apr 01; 10(4):408-19. PubMed ID: 8721985
    [Abstract] [Full Text] [Related]

  • 7. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
    Raval-Pandya M, Freedman LP, Li H, Christakos S.
    Mol Endocrinol; 1998 Sep 01; 12(9):1367-79. PubMed ID: 9731705
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements.
    Staal A, Van Wijnen AJ, Desai RK, Pols HA, Birkenhäger JC, Deluca HF, Denhardt DT, Stein JL, Van Leeuwen JP, Stein GS, Lian JB.
    Endocrinology; 1996 May 01; 137(5):2001-11. PubMed ID: 8612541
    [Abstract] [Full Text] [Related]

  • 10. 1,25-Dihydroxyvitamin D3 stimulates cyclic vitamin D receptor/retinoid X receptor DNA-binding, co-activator recruitment, and histone acetylation in intact osteoblasts.
    Kim S, Shevde NK, Pike JW.
    J Bone Miner Res; 2005 Feb 01; 20(2):305-17. PubMed ID: 15647825
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. DNA bending is induced by binding of vitamin D receptor-retinoid X receptor heterodimers to vitamin D response elements.
    Kimmel-Jehan C, Darwish HM, Strugnell SA, Jehan F, Wiefling B, DeLuca HF.
    J Cell Biochem; 1999 Aug 01; 74(2):220-8. PubMed ID: 10404392
    [Abstract] [Full Text] [Related]

  • 15. Selective recognition of vitamin D receptor conformations mediates promoter selectivity of vitamin D analogs.
    Quack M, Carlberg C.
    Mol Pharmacol; 1999 Jun 01; 55(6):1077-87. PubMed ID: 10347251
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.
    Herdick M, Steinmeyer A, Carlberg C.
    Chem Biol; 2000 Nov 01; 7(11):885-94. PubMed ID: 11094341
    [Abstract] [Full Text] [Related]

  • 18. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
    Imai Y, Pike JW, Koeffler HP.
    Leuk Res; 1995 Mar 01; 19(3):147-58. PubMed ID: 7700077
    [Abstract] [Full Text] [Related]

  • 19. The retinoid X receptor agonist 9-cis-retinoic acid and the 24-hydroxylase inhibitor ketoconazole increase activity of 1,25-dihydroxyvitamin D3 in human skin in vivo.
    Kang S, Li XY, Duell EA, Voorhees JJ.
    J Invest Dermatol; 1997 Apr 01; 108(4):513-8. PubMed ID: 9077483
    [Abstract] [Full Text] [Related]

  • 20. Isolation of baculovirus-expressed human vitamin D receptor: DNA responsive element interactions and phosphorylation of the purified receptor.
    Jurutka PW, MacDonald PN, Nakajima S, Hsieh JC, Thompson PD, Whitfield GK, Galligan MA, Haussler CA, Haussler MR.
    J Cell Biochem; 2002 Apr 01; 85(2):435-57. PubMed ID: 11948698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.